Ivermectin Resources Cancer

by | Jan 1, 2025 | Articles, Cancer, Conditions

Ivermectin Dosing for Cancer Treatment

f3e6bb11 7867 420e b220
June 10, 2024 – “15 minutes with Dr.Makis” – Episode 018: High Dose IVERMECTIN and CANCER
2024 – NEW STUDIES
2024 Fan et al – Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage
(2024 Man-Yuan Li et al) – Ivermectin induces non-protective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells(2024 Kaur et al) – Ivermectin: A Multifaceted drug with a potential beyond anti-parasitic therapy

(2024 Xing Hu et al) – Ivermectin as a potential therapeutic strategy for glioma

(2024 Yang Song et al) – Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma

(2024 Goldfarb et al) – Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell Sensitivities

(2024 Newell et al) – Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy

Oct. 2, 2023 – IVERMECTIN and CANCER, it has at least 15 anti-cancer mechanisms of action. Can Ivermectin Treat COVID-19 mRNA Vaccine Induced Turbo Cancers? – 9 Ivermectin papers reviewed

IVERMECTIN and CANCER RESEARCH:

Top 5 COVID-19 mRNA Vaccine Induced Turbo Cancers are: Lymphoma, Glioblastoma, Breast, Colon, Lung Cancer.

IVERMECTIN can help with mRNA Induced Turbo Cancer, or regular cancers.

Here are recent studies on IVERMECTIN use in certain types of cancer:

BLADDER CANCER – (2024 Fan et al) – Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage

LUNG CANCER – (2024 Man-Yuan Li et al) – Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells

GLIOMA – (2024 Xing Hu et al) – Ivermectin as a potential therapeutic strategy for glioma

MULTIPLE MYELOMA – (2024 Yang Song et al) – Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma

OVARIAN CANCER – (2023 Jawad et al) – Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells

PROSTATE CANCER – (2022 Lu et al) – Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer

COLON CANCER – (2022, Alghamdi et al) – Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats

PANCREATIC CANCER – (2022 Lee et al) – Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction

MELANOMA – (2022 Zhang et al) – Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis

CERVICAL CANCER – (2022, Qabbus et al) – Ivermectin-induced cell death of cervical cancer cells in vitro a consequence of precipitate formation in culture media

HEPATOCELLULAR CARCINOMA – (2022 Lu et al) – Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways

OSTEOSARCOMA – (2022 Hu et al) – Repurposing Ivermectin to augment chemotherapy’s efficacy in osteosarcoma

GASTRIC CANCER – (2021 Rabben et al) – Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer

LEUKEMIA – (2020, de Castro et al) – Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection

ESOPHAGEAL SCC – (2020, Chen et al) – Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma

CHOLANGIOCARCINOMA – (2019 Intyuod et al) – Anti-parasitic drug ivermectin exhibits potent anticancer activity against gemcitabine-resistant cholangiocarcinoma in vitro

BREAST CANCER STEM CELLS – (2018 Dominguez-Gomez et al) – Ivermectin as an inhibitor of cancer stem-like cells.

CML (CHRONIC MYELOID LEUKEMIA) – (2018 Wang et al) – Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress.

RENAL CELL CARCINOMA – (2017 Zhu et al) – Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage

GLIOBLASTOMA – (2016 Liu et al) – Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress.

Related: 

(adapted from https://www.onedaymd.com/2024/07/ivermectin-articles-and-protocols-for.html)

Thanks for sharing this article!